RCHRVEHDGLZISU-ZZEZOPTASA-N(866349-15-7)
- Name: RCHRVEHDGLZISU-ZZEZOPTASA-N
- Synonyms:RCHRVEHDGLZISU-ZZEZOPTASA-N;2H-1-Benzopyran-3-carboxamide, 7-methoxy-2-[(3-methylphenyl)imino]-
- Molecular Formula:C18H16N2O3
- Molecular Weight:308.33
- CAS Registry Number:866349-15-7
- EINECS:
- Melting Point:551.1±60.0 °C(Predicted)
- Water Solubility:
Other Product
- 866317-77-3/Ertapenem Impurity 29
- 866329-04-6/MFCD11557107
- 866329-07-9/Thiazole, 4-chloro-5-(1,3-dioxolan-2-yl)-2-methyl-
- 866330-06-5/[1,1'-Biphenyl]-4-thiol, 4'-(2-[1,1'-biphenyl]-4-yldiazenyl)-
- 866332-17-4/Boronic acid, B-(2-phenyl-5-benzoxazolyl)-
- 866340-65-0/5H-[1]Benzopyrano[2,3-d]pyrimidine, 7-chloro-4-(methylthio)-2-phenyl-
- 866341-20-0/7-(diethylamino)-3-(4-methylphenyl)sulfonylchromen-2-one
- 866344-48-1/2H-1-Benzopyran-2-one, 3-[(4-fluorophenyl)sulfonyl]-
- 866346-41-0/2H-Imidazole-2-thione, 4-(3,4-dimethoxyphenyl)-1-(4-fluorophenyl)-1,3-dihydro-
- 866346-42-1/5-(3,4-dimethoxyphenyl)-3-(4-methylphenyl)-1H-imidazole-2-thione
- 866346-80-7/3-(2,5-dimethoxybenzenesulfonyl)-2H-chromen-2-one
- 866346-83-0/3-(3-chloro-4-fluorophenyl)sulfonyl-8-methoxychromen-2-one
- 866346-84-1/3-(3-chloro-4-fluorophenyl)sulfonyl-7-methoxychromen-2-one
- 866346-86-3/3-(3-chloro-4-fluorobenzenesulfonyl)-7-hydroxy-2H-chromen-2-one
- 866347-83-3/3-(3,4-dimethoxyphenyl)sulfonylchromen-2-one
- 866347-84-4/3-(3,4-dimethoxybenzenesulfonyl)-8-methoxy-2H-chromen-2-one
- 866347-85-5/6-bromo-3-(3,4-dimethoxyphenyl)sulfonylchromen-2-one
- 866347-86-6/6-chloro-3-(3,4-dimethoxyphenyl)sulfonylchromen-2-one
- 866347-88-8/3-(3,4-dimethoxybenzenesulfonyl)-6-methoxy-2H-chromen-2-one
- 866349-15-7/RCHRVEHDGLZISU-ZZEZOPTASA-N
- 866350-26-7/3-(4-Isopropyl-benzenesulfonyl)-4H-[1,2,3]triazolo[1,5-a]quinazolin-5-one
- 866396-70-5/1-[[[(1-Hydroxymethyl)cyclopentyl]amino]acetyl]-2,5-cis-pyrrolidinedicarbonitrile hydrochloride
- 866399-89-5/1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-ethyl ester, calcium salt (2:1), (2R,4S)-
- 866404-53-7/Strychnidin-10-one, 2,3-dimethoxy-, compd. with [3-[(1S)-1-(1,3-benzodioxol-5-yl)-2-[[(2-methoxy-4-methylphenyl)sulfonyl]amino]-2-oxoethyl]-1-methyl-1H-indole-6-carboxylic acid] (1:1)
- 866404-54-8/1H-Indole-6-carboxylic acid, 3-[(1S)-1-(1,3-benzodioxol-5-yl)-2-[[(2-methoxy-4-methylphenyl)sulfonyl]amino]-2-oxoethyl]-1-methyl-, compd. with (αS)-α-methylbenzenemethanamine (2:3)
- 866404-68-4/Geldanamycin, 17-[(2-bromoethyl)amino]-17-demethoxy- (9CI)
- 866404-76-4/2,5-Furandione, dihydro-3,3-dimethyl-4-phenyl-
- 866404-90-2/1H-Indole, 2-ethyl-5-methoxy-3-(4-piperidinyl)-
- 866404-91-3/1H-Indole, 2-ethyl-5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-
- 866404-92-4/8-Azabicyclo[3.2.1]oct-2-ene, 3-(5-chloro-2-methyl-1H-indol-3-yl)-8-methyl-